GSK Operating Expenses 2010-2022 | GSK

GSK annual/quarterly operating expenses history and growth rate from 2010 to 2022. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • GSK operating expenses for the quarter ending June 30, 2022 were $7.342B, a 18.14% decline year-over-year.
  • GSK operating expenses for the twelve months ending June 30, 2022 were $38.225B, a 7.18% increase year-over-year.
  • GSK annual operating expenses for 2021 were $38.383B, a 13.59% increase from 2020.
  • GSK annual operating expenses for 2020 were $33.79B, a 1.23% decline from 2019.
  • GSK annual operating expenses for 2019 were $34.212B, a 1.16% increase from 2018.
GSK Annual Operating Expenses
(Millions of US $)
2021 $38,383
2020 $33,790
2019 $34,212
2018 $33,821
2017 $33,636
2016 $34,277
2015 $20,796
2014 $32,499
2013 $31,083
2012 $30,179
2011 $31,414
2010 $38,053
2009 $31,229
GSK Quarterly Operating Expenses
(Millions of US $)
2022-06-30 $7,342
2022-03-31 $9,364
2021-12-31 $11,675
2021-09-30 $9,844
2021-06-30 $8,970
2021-03-31 $7,895
2020-12-31 $10,033
2020-09-30 $8,769
2020-06-30 $5,924
2020-03-31 $9,064
2019-12-31 $9,036
2019-09-30 $8,925
2019-06-30 $8,132
2019-03-31 $8,118
2018-12-31 $5,293
2018-09-30 $8,055
2018-06-30 $8,889
2018-03-31 $11,584
2017-12-31 $9,421
2017-09-30 $7,811
2017-06-30 $9,386
2017-03-31 $7,018
2016-12-31 $8,689
2016-09-30 $8,026
2016-06-30 $9,589
2016-03-31 $7,889
2015-12-31 $-3,744
2015-09-30 $8,064
2015-06-30 $8,600
2015-03-31 $7,876
2014-12-31 $9,377
2014-09-30 $7,762
2014-06-30 $7,718
2014-03-31 $7,642
2013-12-31 $7,566
2013-09-30 $7,804
2013-06-30 $8,007
2013-03-31 $7,706
2012-12-31 $7,216
2012-09-30 $7,659
2012-06-30 $7,589
2012-03-31 $7,715
2011-12-31 $7,267
2011-09-30 $8,189
2011-06-30 $8,167
2011-03-31 $7,792
2010-12-31 $11,906
2010-09-30 $7,524
2010-06-30 $10,404
2010-03-31 $8,218
2009-12-31 $9,138
2009-09-30 $7,694
2009-06-30 $7,047
2009-03-31 $7,350
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $81.408B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $160.059B 9.71
Bio-Rad Laboratories (BIO.B) United States $15.412B 34.05
QIAGEN (QGEN) Netherlands $11.018B 18.45
Biohaven Pharmaceutical Holding (BHVN) United States $10.535B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.561B 0.00
Arcus Biosciences (RCUS) United States $1.821B 35.53
Myovant Sciences (MYOV) United Kingdom $1.600B 0.00
Emergent Biosolutions (EBS) United States $1.482B 8.59
Zymeworks (ZYME) Canada $0.390B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Gelesis Holdings (GLS) United States $0.104B 0.00
SQZ Biotechnologies (SQZ) United States $0.097B 0.00
Ambrx Biopharma (AMAM) United States $0.089B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00